NCT03706300View on ClinicalTrials.gov

Bioequivalence Study of Guaifenesin and Pseudoephedrine Hydrochloride Extended Release Tablets 1200/120 mg Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Healthy
Interventions
DRUG

Guaifenesin and Pseudoephedrine Hydrochloride Extended Release Tablets 1200/120 mg

Trial Locations (1)

500 037

QPS Bioserve India Pvt. Limited, Hyderabad

Sponsors
All Listed Sponsors
lead

Dr. Reddy's Laboratories Limited

INDUSTRY